Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles

Centers for Disease Control, 1990, Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital—Florida, MMWR Morb Mortal Wkly Rep, 39, 718

Centers for Disease Control, 2000, Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society, MMWR Recomm Rep, 49, 1

Dutt, 2001, Liposomes and PLG microparticles as sustained release antitubercular drug carriers-an in vitro–in vivo study, Int J Antimicrob Agents, 18, 245, 10.1016/S0924-8579(01)00373-9

Sharma, 2001, Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis, Pharm Res, 18, 1405, 10.1023/A:1012296604685

Maincent, 1992, Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats, Pharm Res, 9, 1534, 10.1023/A:1015895804597

Nakada, 1996, Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice, Pharm Res, 13, 38, 10.1023/A:1016017014573

Kreuter, 1994, Drug targeting with nanoparticles, Eur J Drug Metab Pharmacokinet, 19, 253, 10.1007/BF03188928

Couvreur, 1996, Nanoparticles: preparation and characterisation, 183

Kreuter, 1994, Nanoparticles, 219

Knight, 1981

Dalencon, 1997, Atovaquone and rifabutine-loaded nanocapsules: formulation studies, Int J Pharm, 153, 127, 10.1016/S0378-5173(97)00076-8

Lopes, 2000, Polymeric colloidal systems containing ethionamide: preparation and physico-chemical characterization, Pharmazie, 55, 527

Suarez, 2001, Airways delivery of rifampicin microparticles for the treatment of tuberculosis, J Antimicrob Chemother, 48, 431, 10.1093/jac/48.3.431

Pandey, 2003, Poly (d,l-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis, J Antimicrob Chemother, 52, 981, 10.1093/jac/dkg477

Pandey, 2005, Oral solid lipid nanoparticle-based antitubercular chemotherapy, Tuberculosis (Edinb), 85, 415, 10.1016/j.tube.2005.08.009

Bivas-Benita, 2004, Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis, Vaccine, 22, 1609, 10.1016/j.vaccine.2003.09.044

Niwa, 1994, In vitro drug release behavior of d,l-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method, J Pharm Sci, 83, 727, 10.1002/jps.2600830527

Denkbas, 1995, Rifampicin-carrying poly(d,l-lactide) microspheres: loading and release, J Biomater Sci Polym Ed, 6, 815, 10.1163/156856295X00201

Quintanar-Guerrero, 1996, Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique, Int J Pharm, 143, 133, 10.1016/S0378-5173(96)04697-2

Choi, 2002, Thermodynamic parameters on poly(d,l-lactide-co-glycolide) particle size in emulsification-diffusion process, Colloids Surf Physicochem Eng Asp, b201, 283, 10.1016/S0927-7757(01)01042-1

Alex, 1990, Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment, J Microencapsul, 7, 347, 10.3109/02652049009021845

Blanco, 1997, Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres, Eur J Pharm Biopharm, 43, 287, 10.1016/S0939-6411(97)00056-8

Iwata, 1992, Preparation of multi-phase microspheres of poly(d,l-lactic acid) and poly(d,l-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique, J Microencapsul, 9, 201, 10.3109/02652049109021237

Feng, 2001, Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers, J Control Release, 71, 53, 10.1016/S0168-3659(00)00364-3

Ricci, 2004, Leucinostatin-A loaded nanospheres: characterization and in vivo toxicity and efficacy evaluation, Int J Pharm, 275, 61, 10.1016/j.ijpharm.2004.01.030

Holland, 1992, Biodegradable polymers, Vol. 6, 101

1996, Vol. 1, 268